Author

S. L. Maiocchi

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 2 Physiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:mouse· 3 Approach:experimental assay· 2 Research Focus:cell type annotation· 1 Research Focus:clustering· 1 Approach:deep learning· 1 Research Focus:dimensionality reduction· 1 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

E. M. Bahnson· 3 shared A. Cartaya· 2 shared S. Thai· 2 shared A. Akerman· 1 shared A. Anwar· 1 shared A. E. Cartaya· 1 shared G. M. Messinger· 1 shared I. Corbin· 1 shared

Activity by Year

2020-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 23 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersBioengineering

E. M. Bahnson

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Application of Machine Learning and Virtual Reality for Volumetric Analysis of Arterial Lesions

A. E. Cartaya, S. L. Maiocchi, N. Buglak, S. K. Torzone, G. M. Messinger, E. M. Bahnson

This paper applies machine learning and virtual reality tools to improve the volumetric analysis of arterial lesions in animal models of cardiovascular disease.

bioRxiv · Dec 23, 2022 · PreprintPhysiology

Antioxidant Response Activating nanoParticles (ARAPas) localize to atherosclerotic plaque and locally activate the Nrf2 pathway

S. L. Maiocchi, A. Cartaya, S. Thai, A. Akerman, E. M. Bahnson

This study develops ARAPas, nanoparticles that target atherosclerotic plaque and activate the Nrf2 pathway, showing anti-inflammatory effects and increased Nrf2 target gene expression in mouse models.

bioRxiv · Sep 16, 2021Bioengineering

Nrf2 activator-encapsulating polymeric nanoparticles and LDL-like nanoparticles target atherosclerotic plaque

S. L. Maiocchi, S. Thai, A. Cartaya, A. Anwar, I. Corbin, E. M. Bahnson

This study develops and tests two types of nanoparticles that target atherosclerotic plaque to improve delivery of redox-based therapies.

bioRxiv · Jun 10, 2020 · PreprintBioengineering